Related Experiment Video
Updated: Nov 23, 2025
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Metformin: Possible Use of a Diabetes Drug in Treatment of Cancer
Albert Vacheron1, Anne Wynn1, Jeff Zuber1
1Department of Medicine and Preventative Medicine, Research and Medical Service VAMC Memphis and Division of Endocrinology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Abstract:
The biguanide drug metformin used for treating Type 2 diabetes has anticancer properties and affects many pathways involving glucose metabolism, energy balance, and cell survival. A number of retrospective clinical studies have indicated a reduced risk of cancer and improved cancer outcomes in Type 2 diabetic patients taking metformin. Several of its effects are mediated through the induction of cellular stress and subsequent activation of AMP kinase, but many other mechanisms act independently of AMP kinase activation. Metformin has been shown to inhibit the effects of tumor necrosis factor (TNF)-alpha. TNF-alpha interferes with insulin signaling to produce insulin resistance in the insulin signaling pathway and promotes apoptosis through NF-KB in the apoptosis pathway. In addition, metformin reduces cellular proliferation by decreasing the amount of available insulin or by directly affecting the mammalian target of rapamycin complex involved with regulating protein synthesis. It can prevent tumors from acquiring stem cell-like properties, upregulate apoptotic pathways, and bolster the immune system's fight against cancer. Gaining a greater understanding of metformin's various mechanisms of action will continue to elucidate metformin's role as an effective treatment for cancer.
Insights
Metformin, a Type 2 diabetes drug, shows significant anticancer properties by affecting glucose metabolism and cell survival pathways. Clinical studies suggest it reduces cancer risk and improves outcomes in diabetic patients.
Area of Science:
- Oncology
- Endocrinology
- Pharmacology
Background:
- Metformin, a biguanide drug, is a primary treatment for Type 2 diabetes.
- Retrospective studies suggest metformin use is associated with reduced cancer risk and improved outcomes in diabetic patients.
- Metformin influences multiple cellular pathways, including glucose metabolism, energy balance, and cell survival.
Purpose of the Study:
- To explore the anticancer properties and mechanisms of action of metformin.
- To understand how metformin impacts cancer cell proliferation, survival, and immune response.
Main Methods:
- Review of retrospective clinical studies on metformin and cancer outcomes.
- Analysis of metformin's effects on cellular pathways, including AMP kinase, TNF-alpha, and mTOR.
- Investigation of metformin's role in apoptosis, cellular proliferation, and cancer stem cell properties.
Main Results:
- Metformin exhibits anticancer effects through both AMP kinase-dependent and independent mechanisms.
- It inhibits tumor necrosis factor-alpha (TNF-alpha), counteracting insulin resistance and promoting apoptosis.
- Metformin reduces cellular proliferation, prevents cancer stem cell-like properties, upregulates apoptosis, and enhances anti-cancer immune response.
Conclusions:
- Metformin possesses diverse anticancer mechanisms beyond its glucose-lowering effects.
- Further understanding of these mechanisms can establish metformin as a valuable cancer therapeutic.
- Metformin's multifaceted actions highlight its potential in cancer treatment and prevention strategies.
Related Concept Videos
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:27Tumor Immunotherapy
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...